{
     "PMID": "12675124",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20030618",
     "LR": "20171030",
     "IS": "0364-3190 (Print) 0364-3190 (Linking)",
     "VI": "28",
     "IP": "3-4",
     "DP": "2003 Apr",
     "TI": "Characterization of muscarinic autoreceptors in the rabbit hippocampus and caudate nucleus.",
     "PG": "413-7",
     "AB": "Oxotremorine-induced inhibition of electrically evoked release of 3H-acetylcholine from brain slices preincubated with 3H-choline was used to characterize muscarinic autoreceptors in rabbit hippocampus and caudate nucleus. From the shifts to the right of the concentration-response curves of oxotremorine in the presence of muscarinic receptor antagonists, the following pKB values [95% C.I.] were determined in the hippocampus: tripinamide: 8.7 [8.5, 8.8]; himbacine: 8.4 [8.3, 8.5]; AQ-RA 741: 8.3 [8.2, 8.5]; 4-DAMP: 8.2 [8.0, 8.3]; hexahydrosiladifenidol: 7.4 [7.2, 7.5]; AF-DX 116: 7.3 [7.1, 7.4]; pirenzepine: 6.8 [6.6, 7.0]; and PD102807: 6.3 [6.0, 6.5]. In the caudate nucleus: tripinamide: 9.1 [8.9, 9.2]; 4-DAMP: 8.3 [8.2, 8.5]; himbacine: 8.1 [8.0, 8.2]; AQ-RA 741: 8.1 [8.0, 8.3]; hexahydrosiladifenidol: 7.3 [7.2, 7.4]; AF-DX 116: 7.1 [7.0, 7.2]; pirenzepine: 6.7 [6.6, 6.8]; and PD102807: 6.5 [6.2, 6.8]. These pKB values fit best to literature values for M2 receptors, suggesting that the muscarinic autoreceptor of the rabbit hippocampus and caudate nucleus is the m2 gene product.",
     "FAU": [
          "Stoll, C",
          "Schwarzwalder, U",
          "Johann, S",
          "Lambrecht, G",
          "Hertting, G",
          "Feuerstein, T J",
          "Jackisch, R"
     ],
     "AU": [
          "Stoll C",
          "Schwarzwalder U",
          "Johann S",
          "Lambrecht G",
          "Hertting G",
          "Feuerstein TJ",
          "Jackisch R"
     ],
     "AD": "Institut fur Experimentelle und Klinische Pharmakologie und Toxikologie der Universitaat, Neuropharmakologisches Labor, Hansastrasse 9A, D-79104 Freiburg, Germany.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Neurochem Res",
     "JT": "Neurochemical research",
     "JID": "7613461",
     "RN": [
          "0 (Autoreceptors)",
          "0 (Muscarinic Agonists)",
          "0 (Muscarinic Antagonists)",
          "0 (Receptors, Muscarinic)",
          "5RY0UWH1JL (Oxotremorine)",
          "N91BDP6H0X (Choline)",
          "N9YNS0M02X (Acetylcholine)"
     ],
     "SB": "IM",
     "MH": [
          "Acetylcholine/antagonists & inhibitors/metabolism",
          "Animals",
          "Autoreceptors/*metabolism",
          "Caudate Nucleus/*metabolism",
          "Choline/pharmacology",
          "Dose-Response Relationship, Drug",
          "Electric Stimulation",
          "Hippocampus/*metabolism",
          "In Vitro Techniques",
          "Muscarinic Agonists/administration & dosage/pharmacology",
          "Muscarinic Antagonists/pharmacology",
          "Osmolar Concentration",
          "Oxotremorine/administration & dosage/pharmacology",
          "Rabbits",
          "Receptors, Muscarinic/*metabolism"
     ],
     "EDAT": "2003/04/05 05:00",
     "MHDA": "2003/06/19 05:00",
     "CRDT": [
          "2003/04/05 05:00"
     ],
     "PHST": [
          "2003/04/05 05:00 [pubmed]",
          "2003/06/19 05:00 [medline]",
          "2003/04/05 05:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Neurochem Res. 2003 Apr;28(3-4):413-7.",
     "term": "hippocampus"
}